HPV Vaccination Coverage of Male Adolescents in the United States.
BACKGROUND
In 2011, the Advisory Committee for Immunization Practices (ACIP) recommended routine use human papillomavirus (HPV) vaccine for male adolescents.


METHODS
We used the 2013 National Immunization Survey-Teen data to assess HPV vaccine uptake (≥1 dose) and series completion (≥3 doses). Multivariable logistic regression analysis and a predictive marginal model were conducted to identify independent predictors of vaccination among adolescent males aged 13 to 17 years.


RESULTS
HPV vaccination coverage with ≥1 dose was 34.6%, and series completion (≥3 doses) was 13.9%. Coverage was significantly higher among non-Hispanic blacks and Hispanics compared with non-Hispanic white male adolescents. Multivariable logistic regression showed that characteristics independently associated with a higher likelihood of HPV vaccination (≥1 dose) included being non-Hispanic black race or Hispanic ethnicity; having mothers who were widowed, divorced, or separated; having 1 to 3 physician contacts in the past 12 months; a well-child visit at age 11 to 12 years; having 1 or 2 vaccination providers; living in urban or suburban areas; and receiving vaccinations from >1 type of facility (P < .05). Having mothers with some college or college education, having a higher family income to poverty ratio, living in the South or Midwest, and receiving vaccinations from all sexually transmitted diseases/school/teen clinics or other facilities were independently associated with a lower likelihood of HPV vaccination (P < .05).


CONCLUSIONS
Following recommendations for routine HPV vaccination among male adolescents, uptake in 2013 was low in this population. Increased efforts are needed to improve vaccination coverage, especially for those who are least likely to be vaccinated.
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and lhp8@cdc.gov.
Peng-Jun
PJ
Lu
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
David
D
Yankey
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
Jenny
J
Jeyarajah
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
Alissa
A
O'Halloran
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
Laurie D
LD
Elam-Evans
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
Philip J
PJ
Smith
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
Shannon
S
Stokley
Immunization Services Division, National Center for Immunization and Respiratory Diseases, and.
James A
JA
Singleton
Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Eileen F
EF
Dunne
D000293:Adolescent; D006801:Humans; D008297:Male; D053918:Papillomavirus Vaccines; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data*
D053918:Papillomavirus Vaccines